The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the use of circulating tumor DNA (ctDNA) in patients with urothelial cancer in the context of FGFR-targeted therapy.
 
Elena Schönlau
No Relationships to Disclose
 
David Christian Müller
No Relationships to Disclose
 
Gillian Vandekerkhove
No Relationships to Disclose
 
Andrew Murtha
No Relationships to Disclose
 
Jack V.W. Bacon
Stock and Other Ownership Interests - Abcellera; Gilead Sciences; Merck; Novavax
 
Connor Wells
No Relationships to Disclose
 
Kimia Rostin
No Relationships to Disclose
 
Sunil Parimi
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Merck; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer
 
Krista Noonan
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Janssen; Merck; Pfizer
 
Naveen S. Basappa
Stock and Other Ownership Interests - illumiSonics
Honoraria - Astellas Pharma; Eisai; Ipsen; Janssen; Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck; Pfizer; Roche Canada
Travel, Accommodations, Expenses - Eisai; Janssen
 
Jenny J. Ko
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck; Pfizer; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck; Pfizer; Takeda
Research Funding - Bayer
 
Daygen L. Finch
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; Janssen Oncology; Merck; Novartis; Pfizer
Speakers' Bureau - Janssen; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Nimira S. Alimohamed
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; EMD Serono; Merck; Pfizer; Seagen
 
Tarek A. Bismar
Research Funding - GenomeDx (Inst)
 
Lucia Nappi
Honoraria - AstraZeneca; Bayer; Ipsen; Merck Serono; Pfizer
Consulting or Advisory Role - AstraZeneca; Bayer; Ipsen; Pfizer
Research Funding - EMD Serono (Inst); Ipsen (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - IVERMECTIN ANALOGUE COMPOUND THERAPEUTICS FOR HEAT SHOCK PROTEIN-27 (HSP27) INHIBITION, METHODS AND USES ASSOCIATED THEREWITH provisional number: 62/756,707
 
Matti Annala
Leadership - Fluivia
Stock and Other Ownership Interests - Fluivia
 
Cecily Q. Bernales
No Relationships to Disclose
 
Kim N. Chi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; POINT Biopharma; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Constellation Pharmaceuticals; Daiichi Sankyo; ESSA; Janssen; Merck; POINT Biopharma; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Expert Testimony - AstraZeneca; Novartis
 
Alexander William Wyatt
Honoraria - Astellas Pharma; AstraZeneca; AstraZeneca Canada; Janssen; Merck
Consulting or Advisory Role - AstraZeneca
Research Funding - ESSA (Inst)
 
Bernhard J. Eigl
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb/Pfizer; EMD Serono/Merck; Gilead Sciences; Janssen; Pfizer; Roche Canada; Seagen
Consulting or Advisory Role - EMD Serono; Gilead Sciences
Travel, Accommodations, Expenses - EMD Serono